Division of Cell Biology, Medical Research Council Laboratory of Molecular Biology, Cambridge CB2 0QH, United Kingdom; and
Howard Hughes Medical Institute, Janelia Farm Research Campus, Ashburn, VA 20147.
Proc Natl Acad Sci U S A. 2014 Jul 22;111(29):E2967-76. doi: 10.1073/pnas.1405500111. Epub 2014 Jul 7.
The type II clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (Cas) system has emerged recently as a powerful method to manipulate the genomes of various organisms. Here, we report a toolbox for high-efficiency genome engineering of Drosophila melanogaster consisting of transgenic Cas9 lines and versatile guide RNA (gRNA) expression plasmids. Systematic evaluation reveals Cas9 lines with ubiquitous or germ-line-restricted patterns of activity. We also demonstrate differential activity of the same gRNA expressed from different U6 snRNA promoters, with the previously untested U6:3 promoter giving the most potent effect. An appropriate combination of Cas9 and gRNA allows targeting of essential and nonessential genes with transmission rates ranging from 25-100%. We also demonstrate that our optimized CRISPR/Cas tools can be used for offset nicking-based mutagenesis. Furthermore, in combination with oligonucleotide or long double-stranded donor templates, our reagents allow precise genome editing by homology-directed repair with rates that make selection markers unnecessary. Last, we demonstrate a novel application of CRISPR/Cas-mediated technology in revealing loss-of-function phenotypes in somatic cells following efficient biallelic targeting by Cas9 expressed in a ubiquitous or tissue-restricted manner. Our CRISPR/Cas tools will facilitate the rapid evaluation of mutant phenotypes of specific genes and the precise modification of the genome with single-nucleotide precision. Our results also pave the way for high-throughput genetic screening with CRISPR/Cas.
II 型簇状规律间隔短回文重复序列(CRISPR)/CRISPR 相关(Cas)系统最近已成为一种强大的方法,可用于操纵各种生物体的基因组。在这里,我们报告了一个由转基因 Cas9 系和多功能向导 RNA(gRNA)表达质粒组成的高效果蝇基因组工程工具包。系统评估揭示了具有普遍或生殖系限制活性模式的 Cas9 系。我们还证明了来自不同 U6 snRNA 启动子表达的相同 gRNA 的活性不同,以前未测试的 U6:3 启动子具有最强的效果。适当的 Cas9 和 gRNA 组合可靶向必需和非必需基因,其传递率为 25-100%。我们还证明,我们优化的 CRISPR/Cas 工具可用于基于偏移缺口的诱变。此外,与寡核苷酸或长双链供体模板结合使用时,我们的试剂可通过同源定向修复进行精确的基因组编辑,其编辑效率使得选择标记变得不必要。最后,我们展示了 CRISPR/Cas 介导的技术在通过普遍或组织受限方式表达的 Cas9 进行有效双等位基因靶向后,在体细胞中揭示功能丧失表型的新应用。我们的 CRISPR/Cas 工具将有助于快速评估特定基因的突变表型,并以单核苷酸精度精确修饰基因组。我们的结果还为使用 CRISPR/Cas 进行高通量遗传筛选铺平了道路。